| Index | Ligand Name | Structure | PDB code | ligand desolvation |
| 1 | 7ha | Crystal structure of peroxisome proliferator-activatedeceptor alpha (PPARalpha) complex with N-3-((2-(4-Chlorophenyl)-5-methyl-1,3-oxazol-4-yl)methoxy)benzyl)-N-(methoxycarbonyl)glycine | 3kdt | 98.17 |
| 2 | 735 | a crystal structure of PPAR alpha bound with SRC1 peptide and GW735 | 2p54 | 97.82 |
| 3 | nks | Crystal structure of peroxisome proliferator-activatedeceptor alpha (PPARalpha) complex with N-3-((2-(4-Chlorophenyl)-5-methyl-1,3-oxazol-4-yl)methoxy)benzyl)-N-((4-methylphenoxy)carbonyl)glycine | 3kdu | 97.8 |
| 4 | 544 | The 2.5 Angstrom resolution crystal structure of the human PPARalpha ligand binding domain bound with GW409544 and a co-activator peptide. | 1k7l | 97.14 |
| 5 | ro7 | Aleglitazar, a new, potent, and balanced PPAR alpha/gamma agonist for the treatment of type II diabetes | 3g8i | 96.56 |
| 6 | 13m | Human PPAR alpha ligand binding domain in complex with a synthetic agonist APHM13 | 3vi8 | 96.51 |
| 7 | s44 | Human PPAR alpha ligand binding domain in complex with a synthetic agonist TIPP703 | 2znn | 95.88 |
| 8 | mmb | the crystal structure of the human PPARaplpha ligand binding domain in complex with a a-hydroxyimino phenylpropanoic acid | 2npa | 95.83 |
| 9 | az2 | CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN FROM HUMAN PPAR-ALPHA IN COMPLEX WITH THE AGONIST AZ 242 | 1i7g | 95.66 |
| 10 | ctm | Design and biological evaluation of novel, balanced dual PPARa/g agonists | 3fei | 95.03 |
| 11 | rew | Crystal Structure of PPARalpha ligand binding domain with BMS-631707 | 2rew | 94.86 |
| 12 | il2 | Structural basis for iloprost as a dual PPARalpha/delta agonist | 3sp6 | 94.28 |
| 13 | wy1 | Structure of PPARalpha in complex with WY14643 | 4bcr | 92.91 |